X4 Pharmaceuticals Inc (XFOR) Stock Price, Quote & News

Company Profile

X4 Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases of the immune system. It offers XOLREMDI, an orally small-molecule selective antagonist of chemokine receptor CXCR4, which is in phase 3 clinical trial for the treatment of patients with warts, hypogammaglobulinemia, infections, and myelokathexis syndrome. It has a license agreement with Abbisko Therapeutics Co Ltd. to manufac...

Industry: Biotechnology

Sector: Healthcare

Phone: 857 529 8300

Website: www.x4pharma.com

Address:

61 North Beacon Street, 4th Floor, Boston, United States

I_Hate_Stock_Twits May. 15 at 6:42 AM

$XFOR the cart is saying not so fast regarding being range bound. Wait.

0 · Reply

Pope25 May. 4 at 7:11 PM

$XFOR rangebound until ph3 is enrolled. see you in september

0 · Reply

Jeff226 Apr. 29 at 1:14 PM

$XFOR

0 · Reply

DARKP00L Apr. 29 at 11:32 AM

$XFOR 07:14 on Apr. 29 2026 X4 Pharma Says EC Grants Marketing Authorization For XOLREMDI Capsules For Treatment Of Patients With WHIM Syndrome In EU #tradeideas

0 · Reply

TwongStocks Apr. 29 at 11:01 AM

$XFOR X4 Pharmaceuticals Announces European Commission Approval of XOLREMDI® (Mavorixafor), the First and Only Authorized Treatment for Patients with WHIM Syndrome in the European Union https://investors.x4pharma.com/news-releases/news-release-details/x4-pharmaceuticals-announces-european-commission-approval

0 · Reply

I_Hate_Stock_Twits Apr. 24 at 3:30 PM

$XFOR They did sell the prv and that clown woke DEI woman now ex CEO few off to enjoy their Geneva office overseas to be sure.

0 · Reply

Merlintrader Apr. 20 at 9:35 PM

$XFOR X4 Pharmaceuticals ( $XFOR): post-approval reset, new management, and a binary-but-cleaner road toward the 4WARD readout https://merlintrader.com/x4-pharmaceuticals-april2026-deepdive/

0 · Reply

smk8706 Apr. 19 at 5:26 PM

$XFOR hedge fund buying increased by 10 million... good/bad? Whats everyones first thought when they read this?

0 · Reply

Stephanovich7654568 Apr. 7 at 3:13 PM

$RCKT $XFOR . XFOR is an eternal loser. Look at how many stock split events they went trought. RCKT has a chance.

0 · Reply

Zkoko_Bio Apr. 7 at 11:09 AM

$RCKT don't expect much from PRVs. Remember for example when $XFOR sold its PRV for nearly as much as its MC back then? Stock price just acted as if nothing happened...

1 · Reply